David H. Abramson, is a clinician scientist, ophthalmic surgeon, competitive swimmer, and lecturer who has published over 700 peer-reviewed articles in ophthalmology, with a focus on ophthalmic oncology. Abramson was the first chief of the ophthalmic oncology service at Memorial Sloan Kettering Cancer Center, where he is a tenured professor in surgery, pediatrics, and radiation oncology. He is also a professor at Weill Cornell Medicine, where he was the youngest full professor ever appointed in ophthalmology. He pioneered intra-arterial chemotherapy, which cures cancer whilst saving the eye from enucleation, in 2006. He is the recipient of many awards, including the Stallard Medal from the International Society for Oncular Oncology, the Lifetime Achievement Award from the American Academy of Ophthalmology, the Weisenfeld Award from the Association for Research In Vision and Ophthalmology, and the Franceshcetti Medal from the International Society of Genetic Eye Disease in Switzerland.